13.01.2011
- Merck & Co struck an alliance with contract researcher Parexel International to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called...
11.01.2011
- Novartis advanced its bid to copies Roche's multi-billion dollar antibody drug rituximab on Monday, starting phase II trials for its own version of the blockbuster medicine. Drugs...
30.11.2010
- European regulators detailed their long-awaited guidelines on biosimilar antibody drugs on Friday, paving the way for cheaper copies of multi-billion-dollar medicines used to treat...
22.11.2010
- European regulators adopted a new guideline on so-called biosimilar antibody drugs on Friday, paving the way for cheaper copies of multi-billion-dollar medicines for cancer and...
17.11.2010
- European regulators are expected to adopt a conservative stance this week when they set rules for allowing copies of antibody drugs, used to fight cancer, rheumatoid arthritis and...
13.08.2010
- Hard to Copy - Market data shows that sales of biotech products are worth billions of dollars worldwide - just the sort of prospect that normally brings generic manufacturers...
27.05.2010
- Europe's economic jitters will clean out the health-science industry, leaving global generic as well as innovative drugmakers among the survivors, the head of Swiss drugmaker Roche...
26.05.2010
- Israel's Teva Pharmaceutical Industries is developing a generic version of Roche's blockbuster antibody drug Rituxan, highlighting the race to produce so-called biosimilar...
